Home
The Infectious Diseases Clinical Research Consortium (IDCRC) and Vaccine and Treatment Evaluation Units (VTEUs) work in tandem with the National Institute of Allergy and Infectious Diseases (NIAID) as a coordinated national and global network of scientific experts working to develop and test vaccines and other therapies to combat infectious diseases.
About
The IDCRC works through a flexible, sustaining structure to advance new countermeasures and approaches to product development, implement efficient clinical study/trial designs, and support exceptional career development and mentoring of future leaders in infectious diseases clinical research. The consortium's collective experience and access to diverse populations give it the ability to evaluate new vaccines and therapies for infectious diseases.
NIH selects Dr. Jeanne Marrazzo as director of the National Institute of Allergy and Infectious Diseases
Lawrence A. Tabak, DDS, PhD, acting director for the National Institutes of Health, has named Jeanne M. Marrazzo, MD, as director of NIH’s National Institute of Allergy and Infectious Diseases (NIAID). Dr. Marrazzo is currently the director of the Division of Infectious Diseases at the University of Alabama at Birmingham and the LOC co-director, LG Performance Evaluation co-chair for the IDCRC. She is expected to begin her role as NIAID Director in fall 2023. NIAID conducts and supports basic and applied research to better understand, treat and ultimately prevent infectious, immunologic, and allergic diseases.
Read More
COVID-19 Prevention Network
The CoVPN was established by merging four existing NIAID-funded clinical trials networks: the HIV Vaccine Trials Network; the HIV Prevention Trials Network; the Infectious Diseases Clinical Research Consortium; and the AIDS Clinical Trials Group.
More about the CoVPN
News from VTEU Trials
IDCRC Leadership Group
IDCRC Vaccine & Treatment Evaluation Units (VTEUs)
IDCRC Concept Quick Stats
ICP Status
- Approved: 51
- Administratively Not Supported: 28
- Not Approved: 49
- EWG Review: 1
- EWG Liaisons: 1
- EMT Concurrence: 0
- Withdrawn: 14
- Hold: 2
- Moved to Active Study: 2
EWG Assignment
- COVID: 92
- Respiratory: 23
- Emerging Infections: 11
- Enteric Infections: 7
- Malaria/Topical Diseases: 13
- STI: 14
ECP
- EWG Review-In Process: 3
- EMT Review: 2
- Approved-moved to Prioritization: 4
- Not Approved: 13
- Approved-moved to Protocol Development: 10
- Active Study: 10
- EMT Vote: 0
- Other: 7
IDCRC Citation Statement
Please include the following citation in any publications resulting from direct or indirect IDCRC support:
"Supported by the Infectious Diseases Clinical Research Consortium through the National Institute for Allergy and Infectious Diseases of the National Institutes of Health, under award number UM1AI148684. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."